Mereo BioPharma Group Plc (MREO)
0.3798
+0.01
(+3.52%)
USD |
NASDAQ |
Oct 02, 16:00
0.3726
-0.01
(-1.90%)
After-Hours: 20:00
Mereo BioPharma Group Market Cap : 60.62M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 60.62M |
| October 01, 2026 | 58.56M |
| September 30, 2026 | 64.17M |
| September 29, 2026 | 59.57M |
| September 28, 2026 | 59.06M |
| September 25, 2026 | 59.06M |
| September 24, 2026 | 53.87M |
| September 23, 2026 | 54.32M |
| September 22, 2026 | 50.49M |
| September 21, 2026 | 46.31M |
| September 18, 2026 | 48.36M |
| September 17, 2026 | 46.31M |
| September 16, 2026 | 42.46M |
| September 15, 2026 | 45.49M |
| September 14, 2026 | 44.69M |
| September 11, 2026 | 44.69M |
| September 10, 2026 | 39.04M |
| September 09, 2026 | 38.71M |
| September 08, 2026 | 40.64M |
| September 04, 2026 | 39.90M |
| September 03, 2026 | 43.45M |
| September 02, 2026 | 42.65M |
| September 01, 2026 | 44.17M |
| August 31, 2026 | 42.59M |
| August 28, 2026 | 40.30M |
| Date | Value |
|---|---|
| August 27, 2026 | 43.42M |
| August 26, 2026 | 44.37M |
| August 25, 2026 | 44.95M |
| August 24, 2026 | 46.21M |
| August 21, 2026 | 46.35M |
| August 20, 2026 | 46.82M |
| August 19, 2026 | 49.72M |
| August 18, 2026 | 49.96M |
| August 17, 2026 | 49.11M |
| August 14, 2026 | 50.90M |
| August 13, 2026 | 49.11M |
| August 12, 2026 | 48.35M |
| August 11, 2026 | 48.76M |
| August 10, 2026 | 43.48M |
| August 07, 2026 | 47.30M |
| August 06, 2026 | 48.83M |
| August 05, 2026 | 48.44M |
| August 04, 2026 | 51.41M |
| August 03, 2026 | 50.36M |
| July 31, 2026 | 54.70M |
| July 30, 2026 | 50.28M |
| July 29, 2026 | 48.92M |
| July 28, 2026 | 49.39M |
| July 27, 2026 | 48.22M |
| July 24, 2026 | 45.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 4.625B |
| NuCana Plc | 4.698M |
| BioNTech SE | 24.34B |
| Silence Therapeutics Plc | 566.96M |
| Autolus Therapeutics Plc | 473.77M |
Market Cap Related Metrics
| Price to Book Value | 2.116 |
| Price | 0.3798 |
| Earnings Yield | -46.13% |